1. Cysteamine: an old drug with new potential

   Besouw, M., Masereeuw, R., van den Heuvel, L. & Levtchenko, E., Aug-2013, In : Drug Discovery Today. 18, 15-16, p. 785-792 8 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. CRISPR/Cas9: A powerful tool for identification of new targets for cancer treatment

   Liu, B., Saber, A. & Haisma, H. J., Apr-2019, In : Drug Discovery Today. 24, 4, p. 955-970

   Research output: Contribution to journal › Review article › Academic › peer-review

3. When More Isn’t Merrier: Pharmaceutical Alliance Networks and Breakthrough Innovation

   Dong, J. Q. & McCarthy, K. J., Mar-2019, In : Drug Discovery Today. 24, 3, p. 673-677 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders

   Kok, T., Wasiel, A. A., Cool, R. H., Melgert, B. N., Poelarends, G. J. & Dekker, F. J., Nov-2018, In : Drug Discovery Today. 23, 11, p. 1910-1918 9 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. Revisiting asthma therapeutics: focus on WNT signal transduction

   Koopmans, T. & Gosens, R., Jan-2018, In : Drug Discovery Today. 23, 1, p. 49-62 14 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

View all (19) »